Andrew M. Lowy, MD, FACS

Andrew M. Lowy, MD, FACS

Chief Division of Surgical Oncology, Professor of Surgery

Division of Surgical Oncology
UC San Diego Moores Cancer Center

Medical DegreeCornell University Medical College, New York, NY

Fellowship: University of Texas, MD Anderson Cancer Center, Houston, TX

Certifications: General Surgery, Surgical Oncology

Area of Expertise: Cancers of gastrointestinal tract and pancreas

Named a “Top Doc” in San Diego Magazine’s “Physicians of Exceptional Excellence” every year since arriving in San Diego in 2007.  This annual survey is performed in collaboration with the San Diego County Medical Society.

Dr. Lowy, Chief of the Division of Surgical Oncology at the UC San Diego, Moores Cancer Center, is a distinguished surgical oncologist specializing in gastrointestinal cancers.  He has a primary interest and expertise in the treatment of cancers of the pancreas, liver and GI tract. Dr. Lowy has a special interest in the management of patients with metastatic disease to the peritoneum from such cancers as appendix, metastatic colon cancers and peritoneal mesothelioma.

Dr. Lowy is recognized worldwide for his expertise in the surgical treatment of pancreatic cancer. Dr. Lowy is the co-chair of the National Cancer Institute’s Pancreatic Cancer Task Force that is charged with setting the direction of clinical research in pancreatic cancer in the United States. He serves as surgical liaison to the Pancreas Committee of SWOG, one of the largest National Cancer Institute cooperative groups. Dr. Lowy serves on the editorial board of the Annals of Surgical Oncology, acting as section editor for translational research. He is the surgical principal investigator in the largest pancreatic cancer clinical trial conducted in the United States. He directs a basic research laboratory that studies new treatments for pancreatic and gastrointestinal cancers and holds funding from the National Cancer Institute, AACR/PANCAN, and the National Organization of Rare Diseases.

Dr. Lowy is also recognized worldwide for investigating novel cancer treatments that incorporate surgery and chemotherapy to treat patients with advanced cancer that has spread to the abdomen. He has furthered the development of the treatment known as the “chemo bath” or heated intraperitoneal chemotherapy also known as HIPEC, to treat peritoneal based cancers. During surgery, all visible signs of tumour are removed, and a heated chemotherapy solution is circulated throughout the abdomen for up to 90 minutes. The solution is then removed and the incision closed. Dr. Lowy has nearly 20 years of experience treating these types of tumours.

When not at work, Dr. Lowy enjoys playing tennis, traveling and going to baseball games with his wife and three children.

*Please note, Pseudomyxoma Survivor does not endorse individual surgeons or specialists.